Fig 1: Expressions of TLR4/NF-?B signalling pathway-associated proteins semiquantified.
Fig 2: TLR4/NF-?B signalling pathway-associated proteins expression in all groups.
Fig 3: Lgals3 silencing inactivated the TLR4/MyD88/NF‐κB pathway in mice after cerebral IR. (A) Western blot was performed on the brain tissues (peri‐infarct region of the ischemic hemisphere) of mice, and Lgals3 silencing was revealed to inactivate the TLR4/MyD88/NF‐κB pathway in brain tissues of MCAO mice. (B) Co‐IP experiment confirmed a direct interaction. Data were shown as mean ± SD, n = 6. **p < 0.01 vs. Sham group. ## p < 0.01 vs. MCAO + AAV‐shNC group. IR, ischemia‐reperfusion; TLR4, toll‐like receptor 4; MyD88, myeloid differentiation primary response gene 88; NF‐κB, nuclear factor kappa B; MCAO, middle cerebral artery occlusion; Co‐IP, co‐immunoprecipitation; SD, standard deviation.
Supplier Page from Abcam for Anti-TLR4 antibody